8-K: QHSLab Validates Digital Health Tools with Peer-Reviewed Studies, Bolstering Revenue Potential

QHSLab, Inc. announced the publication of two peer-reviewed studies validating its digital assessment tools for enhancing patient outcomes and healthcare efficiency, supporting future revenue growth and provider adoption.

Summary

• QHSLab, Inc. (OTCQB: USAQ) announced the publication of two significant peer-reviewed studies in the last week of May 2025.
• These studies validate the clinical effectiveness and economic benefits of QHSLab's digital assessment tools in primary care settings.
• One study, published in the Journal of Psychosomatic Research, found that help-seeking behaviors in patients with allergic rhinitis are associated with better mental health outcomes, specifically a reduction in the negative impact of allergy symptoms on anxiety and depression.
• The second study, featured in Consultant360, introduced the Q-Scale, a tool designed to predict healthcare overutilization by assessing patients' psychosocial, affective, and somatic factors, enabling targeted interventions and optimizing resource utilization.
• These publications are expected to support QHSLab's commercial claims and strengthen the foundation for reimbursement, provider adoption, and revenue growth.
• The digital tools are designed to facilitate personalized, early intervention, optimize resource utilization, and enhance financial viability for practices by supporting CPT-coded reimbursable services.

Sentiment

Score: 8

Explanation: The announcement is highly positive, detailing the successful peer-reviewed validation of the company's core digital health tools. This validation is crucial for commercial claims, reimbursement, and future revenue growth, indicating strong progress in their strategic objectives and de-risking their business model.

Positives

• Publication of two significant peer-reviewed studies validating the clinical effectiveness and economic benefits of QHSLab's digital assessment tools.
• The studies support the company's commercial claims and strengthen the foundation for reimbursement, provider adoption, and future revenue growth.
• Digital tools enable personalized, early intervention in patient care, improving outcomes through early detection, cognitive profiling, and risk stratification.
• The Q-Scale tool helps optimize resource utilization by identifying high-risk patients and potentially reducing unnecessary healthcare visits.
• The tools support CPT-coded reimbursable services, allowing primary care providers to capture new revenue streams.
• QHSLab operates in high-growth areas of healthcare, including mental health, preventative screening, and AI-supported care, with scientific and economic validation.

Risks

• The timing of the introduction of new products may vary.
• There is an inherent discrepancy in actual results compared to estimates, projections, and forecasts made by management.
• Regulatory delays could impact the company's operations and product adoption.
• Changes in government funding and budgets may affect the healthcare landscape and the company's business.
• General economic conditions not within the Company's control could impact performance.

Future Outlook

QHSLab expects the peer-reviewed validation of its digital tools to significantly drive provider adoption, secure reimbursement, and lead to future revenue growth. The company aims to deliver long-term value to investors by aligning scientific advancement with scalable business outcomes and continuing to embed clinical-grade, reimbursable digital medicine tools into primary care settings.

Management Comments

• Troy Grogan, CEO: "These studies are a clear signal to the market that QHSLab is not only operating in high-growth areas of healthcare—mental health, preventative screening, and AI-supported care—but is doing so with scientific and economic validation. For our shareholders, this research supports our commercial claims and strengthens the foundation for reimbursement, provider adoption, and revenue growth. We’re aligning scientific advancement with scalable business outcomes, and that’s how we intend to deliver long-term value to our investors."
• Dr. Marcos A. Sanchez-Gonzalez, VP of Medical and Scientific Affairs: "These publications reflect years of clinical design, data collection, and validation in real-world primary care environments. The findings offer practical, evidence-based tools for providers to improve patient care through early detection, cognitive profiling, and risk stratification. For patients, these tools mean more personalized care and better outcomes. The studies demonstrate that QHSLab’s digital solutions are innovative and rooted in sound scientific evidence, making the digital tools ready for widespread clinical use and improving quality of care."

Industry Context

The announcement positions QHSLab within the rapidly expanding digital health sector, emphasizing personalized medicine, population health screening, and AI-supported care. The peer-reviewed validation of their digital assessment tools aligns with broader industry trends towards evidence-based digital solutions that aim to improve patient outcomes, optimize healthcare resource utilization, and create new revenue streams for healthcare providers, particularly within primary care settings.

Stakeholder Impact

• Shareholders: The research supports commercial claims, strengthens the foundation for reimbursement, provider adoption, and revenue growth, aligning scientific advancement with scalable business outcomes to deliver long-term value.
• Patients: Benefit from more personalized care, better outcomes, early detection, cognitive profiling, and risk stratification through the validated digital tools.
• Providers (Physicians/Practices): Gain practical, evidence-based tools to improve patient care, optimize resource utilization, reduce unnecessary visits, and capture new revenue streams through CPT-coded reimbursable services.

Next Steps

• Continue efforts to embed clinical-grade, reimbursable digital medicine tools into primary care settings.
• Further commercialization efforts based on the validated scientific foundation of their digital solutions.

Key Dates

Recommendation

Keywords

Digital health, personalized medicine, population health screening, point of care diagnostics, primary care, peer-reviewed studies, patient outcomes, healthcare efficiency, mental health, allergic rhinitis, Q-Scale, healthcare overutilization, AI-supported care, CPT codes, reimbursement, revenue growth